News

ASH is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 60th ASH Annual Meeting, December 1-4 in San Diego.
Read more on American Society of Hematology »
Researchers have uncovered an association between RNA abnormalities and multiple myeloma progression. The findings offer novel insights for new, effective therapeutic strategies to be developed.
Read more on Science Daily »
Skeletal stem cells are valuable because it's thought they can heal many types of bone injury, but they're difficult to find because researchers don't know exactly what they look like or where they live.
Read more on Science Daily »
A cancer therapy based on fusing two types of cells into a single unit shows promise in strengthening existing treatments for acute myeloid leukemia. The approach joins blood platelets that carry cancer drugs with stem cells that guide the platelets…
Read more on Science Daily »
Researchers have shed new light on a molecule called TIM-3 that might play a key role in the regulation of the immune response.
Read more on Science Daily »
Researchers have devised a way to help blood cells regenerate faster, by stimulating a particular type of stem cell to secrete growth factors that help blood cell precursor cells differentiate into mature blood cells. This could help repopulate blood cells…
Read more on Science Daily »
Researchers have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely benefit from this treatment. In a mouse model, the experimental treatment eliminated all signs…
Read more on Science Daily »
Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia.
Read more on Science Daily »
For the first time ever, researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a recurrence of lethal, metastatic cancer.
Read more on Science Daily »
The American Society of Hematology (ASH) will recognize J. Evan Sadler, MD, PhD, with the 2018 Exemplary Service Award for his exceptional years of service and dedication to ASH and to hematology.
Read more on American Society of Hematology »
Researchers have genetically engineered a new laboratory model that enables accurate testing of anti-cancer drugs by mimicking the complexity of human cancers. Using this advanced model, researchers will be able to discover the safest and most effective ways to use…
Read more on Science Daily »
ASH announced the names of eight investigators who have each been awarded $150,000 through the ASH Bridge Grant Program. Designed to support promising hematology research, ASH Bridge Grants will ensure that innovative research continues at institutions across the country.
Read more on American Society of Hematology »
An emerging treatment known as adoptive T-cell therapy has proven effective in a Phase II clinical trial for treating progressive multifocal leukoencephalopathy (PML), a rare and often fatal brain infection sometimes observed in patients with cancer and other diseases in…
Read more on Science Daily »
Pediatric researchers studying the life-threatening blood disorder Fanconi anemia have devised a method to block the abnormal biological signals that drive the disease. This proof-of-concept finding in animals and stem cells from human cord blood may lay the foundation for…
Read more on Science Daily »
New research suggests that a type of 'supercharged' immune cell could be mass-produced to help fight cancer.
Read more on Science Daily »
For some patients with difficult-to-treat leukemia and lymphoma, the investigational oral medicine duvelisib may significantly improve disease outcomes, according to phase III trial data published today in the journal Blood.
Read more on American Society of Hematology »
ASH announced the names of 16 outstanding fellows selected to receive the 2018 ASH Research Training Award for Fellows, a year-long program that aims to encourage careers in academic hematology by providing protected research time during training.
Read more on American Society of Hematology »
ASH announced the names of 29 medical students selected to take part in the 2018 Minority Medical Student Award Program.
Read more on American Society of Hematology »
ASH announced the names of 17 medical students and 14 residents selected to receive the 2018 Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award.
Read more on American Society of Hematology »